← FDA DRUG APPROVALS

FDA ANDA · ANDA075450

METHYLPHENIDATE HYDROCHLORIDE

Sponsor: HERITAGE PHARMA

APPLICATION
ANDA075450
TYPE
ANDA
ORIGINAL APPROVAL
2001-12-21
LATEST ACTION
2025-09-23
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

METHYLPHENIDATE HYDROCHLORIDEDiscontinued
METHYLPHENIDATE HYDROCHLORIDE 20MG · TABLET, EXTENDED RELEASE · ORAL

Approval history

2025-09-23Labeling · Supplement 9 · standardAP
2021-06-25Labeling · Supplement 8 · standardAP
2001-12-21OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →